Kwang Dong Pharmaceutical Co., Ltd. Stock: price and insider trades · South Korea
광동제약
No insider purchase over the last 90 days. The latest, by 설상현, was filed 10 Mar 2026.
Key facts
Headquarters: Gwacheon, South Korea · Founded: 1963
Source: Wikidata (CC0).
Who traded when
BuySale+1 other insider
Since the insiders bought
- -32.2%Entry ₩9,200 · Close 30 Oct 2026 ₩6,240
- -32.2%Entry ₩9,200 · Close 30 Oct 2026 ₩6,240
- -32.2%Entry ₩9,200 · Close 30 Oct 2026 ₩6,240
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- Other0DART
- Other0DART
- ●Executives0DART
- 0KRXDART:20260414002496
- 7,868 shares@ ₩7,260.000.012% mcap100.0% of flowShareKRXDART:20260309001931Canonical exit: 28 May 2026 (T+90)
- 4,666 shares@ ₩7,293.5230.013% mcap100.0% of flowShareKRXDART:20260309001932
- 6,613 shares@ ₩7,260.000.015% mcap100.0% of flowShareKRXDART:20260309001933Canonical exit: 28 May 2026 (T+90)
- 5,878 shares@ ₩7,260.000.014% mcap100.0% of flowShareKRXDART:20260309001928Canonical exit: 28 May 2026 (T+90)
- 7,347 shares@ ₩7,260.000.017% mcap100.0% of flowShareKRXDART:20260309001897Canonical exit: 28 May 2026 (T+90)
- 5,878 shares@ ₩7,260.000.014% mcap100.0% of flowShareKRXDART:20260309001913Canonical exit: 28 May 2026 (T+90)
- 5,878 shares@ ₩7,260.000.014% mcap100.0% of flowShareKRXDART:20260309001921Canonical exit: 28 May 2026 (T+90)
- 115,953 sharesKRXDART:20260309001894
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- 130,000 sharesKRXDART:20250408003206Canonical exit: 7 Jul 2025 (T+90)
- 0KRXDART:20241227000705
- 50,000 sharesKRXDART:20241008000371Canonical exit: 26 Dec 2024 (T+90)
- 0KRXDART:20240726000479
- 0KRXDART:20240628000824
- 22,500 sharesKRXDART:20240411003462
- 111,000 sharesKRXDART:20240208000666Canonical exit: 5 May 2024 (T+90)
- 0KRXDART:20231012000325
25 of 50 declarations
About Kwang Dong Pharmaceutical Co., Ltd.
On February 27, 2026, 6 executives of 광동제약 (Kwang Dong Pharmaceutical Co., Ltd.) bought shares on the same day, EUR 158,257 in all. Across the full history, 6 purchase filings are classed as clustered. The three largest purchases: EUR 31,523 for 박상영 (대표이사(사장)), EUR 28,374 for 박원호 (전무이사) and EUR 25,221 for 설상현 (상무이사).
The record holds 47 filings from 9 filers, published from March 11, 2021 to June 30, 2026. Among them are 10 purchases, 6 with an amount (median EUR 25,221), and 2 sales, or 83% purchases. 최성원, filed as 대량보유자, has 33 of them, including 3 purchases and 2 sales, which makes this the top filer. 배기룡 (전무이사) signs 2 purchases and 구준모 (상무이사) one.
Read moreShow less
The South Korean company is valued at KRW 332.0 billion, and insiders hold 19.6% of it. The yearly volume runs from 4 filings in 2025 to 11 in 2026; 2021 and 2022 have 9 each. Over the last twelve months: 12 filings, of which 6 purchases and 1 sale. Publication takes a median of 4 days.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
